Migrant Health Country Profile tool (MHCP-t) for transforming health data collection and surveillance in the Middle East and North African (MENA) region: tool development protocol with embedded process evaluation.

Introduction: The Middle East and North Africa (MENA) region is characterised by major health disparities and complex migration flows. Yet, because of a lack of epidemiological data, there is an urgent need to strengthen routine data collection around migrant health and to define key indicators towards migrant health monitoring. To address this problem, we aim to design and pilot test the Migrant Health Country Profile tool (MHCP-t) which can collate country-level data collection around migration health data, policies and healthcare provision.

The role of human intestinal mucus in the prevention of microplastic uptake and cell damage.

An increase in plastic waste and its release into the environment has led to health concerns over microplastics (MPs) in the environment. The intestinal mucosal layer is a key defense mechanism against ingested MPs, preventing the migration of particles to other parts of the body. MP migration through intestinal mucus is challenging to study due to difficulties in obtaining intact mucus layers for testing and numerous formulations, shapes, and sizes of microplastics.

Hazardous gas emissions from drop-in biofuels: mutagenicity, cytotoxicity, and unregulated pollutants.

This study investigates cancer-related mutations (TA98 and YG5185 strains/Ames test), cell death (human A549 cell line/MTT assay) and unregulated pollutants (16 PAH, 13 carbonyls) from the gas exhaust emissions from a last-mile delivery vehicle following the WLTC driving cycle, operating with hydrotreated vegetable oil and biodiesel. Both biofuels were used pure and blended 20 % by volume with diesel fuel. Gas phase samples were collected using XAD-2 Amberlite® resin.

A Conservative Restorative Approach for a Patient With Cleft Palate: Replacing a Lateral Incisor and Enhancing Esthetics.

Young patients often times are poor candidates for implant-supported restorations due to ongoing jawbone development. This case report describes a viable restorative option for a 16-year-old patient who had a large cleft defect and a hopeless prognosis for the right lateral incisor. The clinician utilized a combination of a fixed bonded ceramic restoration to replace tooth No.

Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke.

The blood enzyme glutamate-oxaloacetate transaminase (GOT) has been postulated as an effective therapeutic to protect the brain during stroke. To demonstrate its potential clinical utility, a new human recombinant form of GOT (rGOT) was produced for medical use. We tested the pharmacokinetics and evaluated the protective efficacy of rGOT in rodent and non-human primate models that reflected clinical stroke conditions.